Current Report Filing (8-k)

Date : 10/12/2018 @ 10:17PM
Source : Edgar (US Regulatory)
Stock : Heyu Biological Technology Corporation (HYBT)
Quote : 0.0245  -0.0001 (-0.41%) @ 8:59PM

Current Report Filing (8-k)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K  

 

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 12, 2018 ( October 12, 2018)

  

 

 

Heyu Biological Technology Corporation

(Exact Name of Registrant as Specified in its Charter)

 

 

Nevada

 

 

000-26731  

 

 

87-0627910  

(State or Other Jurisdiction of Incorporation)

 

 

 

(Commission  File Number)

 

 

(IRS Employer Identification Number) 

    

4th Floor, No. 10 Building, Xinglin Bay Business Operation Center,

Jimei District, Xiamen City,

Fujian Province, China 361022

(Address of Principal Executive Offices, Zip Code)

 

Registrant’s telephone number, including area code: (86) 158 5924 0902

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

   

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Appointment of New Director – Kwee Huwa Tan

 

On October 12, 2018, Ms. Kwee Huwa Tan was appointed to the Board of Directors of the Company to serve as a director of the Company.

 

Ms. Kwee Huwa Tan, age 54, is a sales & marketing expert with a strong entrepreneurial spirit. Since April 2017, Ms. Tan has been a director for Heyu Leisure Holidays Corporation, a U.S. public company managing budget hotels in China. In 2012, Ms. Tan founded Isbel Beauty Centre., a provider of primer skin care products in Malaysia, and she has been the Chief Executive Officer of Isbel Beauty Centre since 2012. Ms. Tan has also served as the Chief Advisor to Heyu Biological Technology Corporation (Xiamen) since 2013 where she was tasked with developing networking opportunities, analyzing profitability of products and market potentials and cultivating prospective clients. Ms. Tan earned her bachelor degree in Business Administration from Ansted University in Malaysia in 1986.

 

Ms. Tan does not have any family relationship with any director or executive officer of the Company and has not been involved in any transaction with the Company during the past two years that would require disclosure under Item 404(a) of Regulation S-K.

 

  1  

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Heyu Biological Technology Corporation
   
  By:  /s/ Ban Siong Ang
 

Name:

Title:

Ban Siong Ang
Chief Executive Officer
     
  Date: October 12, 2018
     

 

  2  

 

Heyu Biological Technology (USOTC:HYBT)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more Heyu Biological Technology Charts.

Heyu Biological Technology (USOTC:HYBT)
Intraday Stock Chart

Today : Wednesday 24 July 2019

Click Here for more Heyu Biological Technology Charts.

Latest HYBT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.